4.6 Article

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma

Min Li et al.

Summary: This study elucidated the mechanisms of iron's enhancement activity on HCC metastasis and identified SPNS2 as a potential therapeutic target for preventing HCC pulmonary metastasis.

MOLECULAR THERAPY (2022)

Review Biochemistry & Molecular Biology

The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?

Youchao Qi et al.

Summary: The G-protein-coupled bile acid receptor, TGR5, is activated by bile acids and regulates various biological processes through multiple signaling pathways. It is widely distributed in different tissues and has inconsistent effects in different cancer cells.

MOLECULES (2022)

Editorial Material Gastroenterology & Hepatology

Recent Advances in Hepatocellular Carcinoma Treatment

Neehar D. Parikh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

Tianli Chen et al.

Summary: The study revealed that FGF19 and FGFR4 are adverse prognostic biomarkers for gallbladder carcinoma, with their co-expression being a more sensitive predictor. FGF19 can promote GBC progression by stimulating FGFR4 activation via an autocrine pathway with bile as a potential carrier.

ONCOGENE (2021)

Article Oncology

Hepatobiliary Cancers, Version 2.2021

Al B. Benson III et al.

Summary: The NCCN Guidelines for Hepatobiliary Cancers provide recommendations for screening, diagnosis, staging, treatment, and management of HCC, gallbladder cancer, and cancer of the bile ducts. A multidisciplinary evaluation is crucial for determining optimal treatment strategies, with significant advancements in systemic treatment of HCC beyond traditional options like sorafenib.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Gastroenterology & Hepatology

Liquid biopsy in the clinical management of hepatocellular carcinoma

Johann von Felden et al.

Article Oncology

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

John D. Gordan et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

O. Erice et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Multidisciplinary Sciences

TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue

Laura A. Velazquez-Villegas et al.

NATURE COMMUNICATIONS (2018)

Review Gastroenterology & Hepatology

Role of TGR5 (GPBAR1) in Liver Disease

Verena Keitel et al.

SEMINARS IN LIVER DISEASE (2018)

Article Gastroenterology & Hepatology

Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon

Joseph B. J. Ward et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)

Article Biochemistry & Molecular Biology

Bile Acids in Physiology, Pathology and Pharmacology

Jose J. G. Marin et al.

CURRENT DRUG METABOLISM (2016)

Review Multidisciplinary Sciences

Hypoxic control of metastasis

Erinn B. Rankin et al.

SCIENCE (2016)

Article Gastroenterology & Hepatology

Prognosis prediction and staging

Alejandro Forner et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)

Review Biochemistry & Molecular Biology

Bile acids are nutrient signaling hormones

Huiping Zhou et al.

STEROIDS (2014)

Article Gastroenterology & Hepatology

Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling

Anatoliy I. Masyuk et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)

Article Chemistry, Medicinal

2-Phenoxy-nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)

Rainer E. Martin et al.

CHEMMEDCHEM (2013)

Review Biochemistry & Molecular Biology

Hepatobiliary transport in health and disease

Jeannie Chan et al.

CLINICAL LIPIDOLOGY (2012)

Article Endocrinology & Metabolism

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice

Takaharu Maruyama et al.

JOURNAL OF ENDOCRINOLOGY (2006)

Article Biochemistry & Molecular Biology

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation

Galya Vassileva et al.

BIOCHEMICAL JOURNAL (2006)